第一单位：
Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
作者：
Li-Juan,Deng [1]
;
Ke-Shu,Zhou [2]
;
Li-Hong,Liu [3]
;
Ming-Zhi,Zhang [4]
;
Zhi-Ming,Li [5]
;
Chun-Yan,Ji [6]
;
Wei,Xu [7]
;
Ting,Liu [8]
;
Bing,Xu [9]
;
Xin,Wang [10]
;
Su-Jun,Gao [11]
;
Hui-Lai,Zhang [12]
;
Yu,Hu [13]
;
Yan,Li [14]
;
Ying,Cheng [15]
;
Hai-Yan,Yang [16]
;
Jun-Ning,Cao [17]
;
Zun-Min,Zhu [18]
;
Jian-Da,Hu [19]
;
Wei,Zhang [20]
;
Hong-Mei,Jing [21]
;
Kai-Yang,Ding [22]
;
Xiang-Yang,Zhang [23]
;
Ren-Bin,Zhao [23]
;
Bin,Zhang [23]
;
Ya-Min,Tian [23]
;
Yong-Ping,Song [2]
;
Yu-Qin,Song [1]
;
Jun,Zhu [1]
作者单位：
Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
[1]
Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
[2]
Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
[3]
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
[4]
Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, China.
[5]
Department of Hematology, Qilu Hospital, Shandong University, Jinan, China.
[6]
Department of Hematology, Pukou CLL Center, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
[7]
Department of Hematology, West China Hospital of Sichuan University, Chengdu, China.
[8]
Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen, China.
[9]
Department of Hematology, Shandong Provincial Hospital, Jinan, China.
[10]
Department of Hematology, The First Hospital of Jilin University, Changchun, China.
[11]
Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
[12]
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
[13]
Department of Lymphoma, The First Affiliated Hospital of China Medical University, Shenyang, China.
[14]
Department of Oncology, Jilin Provincial Cancer Hospital, Changchun, China.
[15]
Department of Lymphoma, Zhejiang Cancer Hospital, Hangzhou, China.
[16]
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
[17]
Institute of Hematology, Henan Provincial People's Hospital, Zhengzhou, China.
[18]
Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
[19]
Department of Hematology, Peking Union Medical College Hospital, Beijing, China.
[20]
Department of Hematology, Peking University Third Hospital, Beijing, China.
[21]
Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
[22]
InnoCare Pharma Limited, Beijing, China.
[23]
DOI
10.1182/bloodadvances.2022009168
PMID
37078706
发布时间
2023-08-23
换一批
